
News|Articles|May 17, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 17, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC)  as of today, May 17, 2022, at 3:00 PM, EDT:
46.4% of fully vaccinated persons in the US  have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 66.5% of total US population
• 70.7% of US population aged ≥5 years
• 74.9% of US population aged ≥12 years
• 76.4% of US population aged ≥18 years
• 90.7% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, May 17, 2022 at 5:20 PM, EDT, there have been:
• 82 706 184  confirmed cases and
• 1 000 091   deaths
• 1 000 091 deaths
In the past 28 days, the 3 states with the most new cases are:
1. New York: 229 398 
2. California: 187 067 
3. Illinois: 125 957 
2. California: 187 067
3. Illinois: 125 957
Deaths: California has the highest number of deaths due to COVID-19 with 90 868 reported fatalities, followed by Texas with 88 263 and Florida with 74 241. 
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 524 454 506 confirmed cases, 6 280 804 deaths, and 11 419 801 741 vaccine doses administered. 
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Quiz: Recent Advances in Menopause and Midlife Women’s Health Research
2
EPIC-Norfolk Study Supports Universal Screening for Three Cardiovascular Biomarkers
3
Tezepelumab Achieves Dual Benefit in Severe Asthma, Improving Control with Reduced Steroid Dependence
4

































































































































































































































































































